Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers and the second leading cause of cancer-related deaths in men worldwide. Surgical resection of HCC remains the mainstay treatment procedure. As a result of hepatitis viral infection, the postoperative survival outcome in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiansong, Yin, Zhiwei, Cao, Liuxia, Xu, Xiaodan, Yan, Tao, Liu, Changting, Li, Diangeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076097/
https://www.ncbi.nlm.nih.gov/pubmed/29995763
http://dx.doi.org/10.1097/MD.0000000000011295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076097/
https://www.ncbi.nlm.nih.gov/pubmed/29995763
http://dx.doi.org/10.1097/MD.0000000000011295

Ejemplares similares